{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2023"],"data_sharing_plan":["IPD Sharing (as of September 2023): No"],"condition":["Metastatic Colorectal Cancer","Colorectal Neoplasms"],"disease":["Metastatic Colorectal Cancer","Colorectal Neoplasms"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/92929"],"location":["Egypt"],"study_start_month":["3"],"keyword":["Nitazoxanide"],"repository":["ECRIN MDR"],"study_status":["Recruiting"],"additional_accession":[]},"is_claimable":false,"name":"Nitazoxanide in Patients With Metastatic Colorectal Cancer","description":"The aim of this study is to evaluate the potential efficacy and safety of nitazoxanide in patients with metastatic colorectal cancer.","dates":{"creation":"2023-03-15"},"accession":"92929","cross_references":{"ClinicalTrials___gov":["NCT06049901"]}}